Pharmafile Logo

Volt Pharma Associates

VPA supports life sciences companies, investors and academic institutes in developing new products, technologies and innovative approaches. VPA’s aim is to solve our clients’ product research, development and commercialisation challenges so they can achieve their business goals.

This is a FREE LISTING on PMHUB

Below are full profiles from other companies in related areas

Genesis Research Group

Genesis Research Group empowers life science companies to innovate differently by fundamentally transforming the way they engage with research partners. Through the integration of robust stakeholder insights (RPR), data-agnostic expertise,…

View Profile

Company Details

Engesserstrasse 4B, Freiburg, 79114, Germany
+49 172 6340202

 Latest Content from PMHub 

Enhancing Continuity with Online Meetings – Perks of Virtual Medical Education

Explore the power of online meetings for superior continuity in our latest video from the "Perks of Virtual Medical Education" series. Learn how shorter, more frequent virtual touchpoints allow for...

Mtech Access host transforming healthcare symposium

Press Releases | August 7, 2024 | Petauri Evidence

• Mtech Access are once again hosting a symposium looking at transforming the healthcare landscape in the UK and how to foster NHS–industry collaboration • Guest speakers from across the...

Caring for patients’ mental health in clinical trials

We look at why ensuring continuous mental health support for patients in clinical trials is essential to enhance their overall well-being and trial engagement.

The value of medical education in driving commercial success

Onyx Health's Sarah Seilly discusses how innovative, data-driven approaches to medical education and strategic collaborations with HCPs can drive engagement and ensure commercial success in an evolving healthcare industry.

[Free Whitepaper] 6 reasons why direct patient support is a ‘must have’ for your clinical trials

This white paper explores the importance of patient-first services and why direct patient support is crucial for the success of sponsors’ clinical trials. Download it for FREE 👉🏽  https://innovativetrials.com/six-reasons-why-direct-patient-support-is-a-must-have-for-your-clinical-trials/ 

Assessing opportunities for manufacturers to communicate the value of therapies to oncology clinical pathway (OCP) developers

Based on insights from 15 U.S. payers and providers, this white paper explores how manufacturers can effectively engage oncology clinical pathway (OCP) developers.

Leading the Way at ESC 2024

Anticipation is building at Medscape Education as the team prepares for the ESC 2024 Congress. We are excited to announce a significant presence during the congress including a booth (#H500)...

Driving equitable healthcare: The role of DE&I in clinical trials

Diversity, equity and inclusion (DE&I) is becoming a bigger topic of conversation and meaningful action within clinical trials. And for good reason, too. Find out why we embrace this and...

Uniting Communities for Rare Disease Clinical Trial Success

Step into the realm of innovation and collaboration in patient recruitment and retention with our upcoming webinar, "Bridging Boundaries: Uniting Communities for Rare Disease Clinical Trial Success." Delve deep into...

Patient Recruitment & Retention Strategies in the 2024 Clinical Trial Landscape

In the landscape of the clinical trial industry in 2024, persistent challenges persist in the realms of patient recruitment and retention. These hurdles, having endured over several years, continue to...